FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Glyburide (GLYNASE) Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Pfizer Pharmaceuticals (New 01/03/2023)

Company Contact Information:
800-533-4535

Presentation	Posting Date	Related Information
1.5 tablet; Bottle of 100 (NDC 0009-0341-01)	01/03/2023	Discontinuation of the manufacture of the drug. Supply expected to exhaust early February 2023.
3 mg tablet; Bottle of 100 (NDC 0009-0352-01)	01/03/2023	Discontinuation of the manufacture of the drug. Supply expected to exhaust early November 2023.
6 mg tablet; Bottle of 100 (NDC 0009-3449-01)	01/03/2023	Discontinuation of the manufacture of the drug. Supply expected to exhaust early February 2023.
6 mg tablet; Bottle of 500 (NDC 0009-3449-03)	01/03/2023	Discontinuation of the manufacture of the drug. Supply expected to exhaust early February 2023.